Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Nikolaos Tentolouris"'
Autor:
Ourania Zacharopoulou, Georgia Samakidou, Ioanna Eleftheriadou, Anastasios Tentolouris, Nikolaos Chatzieleftheriou, Ourania Kosta, Nikolaos Tentolouris
Publikováno v:
Hellenic Journal of Cardiology, Vol 68, Iss , Pp 68-69 (2022)
Externí odkaz:
https://doaj.org/article/70daff86648e4c1794fac7474c60a376
Autor:
Ernestini Tyfoxylou, Nick Voulgaris, Chris Gravvanis, Sophia Vlachou, Athina Markou, Labrini Papanastasiou, Nikolaos Tentolouris, Eva Kassi, Gregory Kaltsas, George P. Chrousos, George P. Piaditis
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2308 (2022)
Primary aldosteronism (PA) is the most common cause of endocrine hypertension. The prevalence of hypertension is higher in patients with diabetes mellitus-2 (DM-2). Following the limited existing data, we prospectively investigated the prevalence of
Externí odkaz:
https://doaj.org/article/4d05e6dc492641b08e95a1052ca40683
Autor:
Vasiliki Mamakou, Sophie Hackinger, Eleni Zengini, Evgenia Tsompanaki, Eirini Marouli, Ioannis Serafetinidis, Bram Prins, Athina Karabela, Eirini Glezou, Lorraine Southam, Nigel W. Rayner, Karoline Kuchenbaecker, Klea Lamnissou, Vassilis Kontaxakis, George Dedoussis, Fragiskos Gonidakis, Anastasia Thanopoulou, Nikolaos Tentolouris, Eleftheria Zeggini
Publikováno v:
BMC Psychiatry, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Schizophrenia (SCZ) is associated with increased risk of type 2 diabetes (T2D). The potential diabetogenic effect of concomitant application of psychotropic treatment classes in patients with SCZ has not yet been evaluated. The ov
Externí odkaz:
https://doaj.org/article/c570450c1dd64cc19c48500a135ea39c
Autor:
Agron Ylli, Andrej Janez, Nikolaos Tentolouris, Cristian Serafinceanu, Nicolae Hancu, Tsvetalina Tankova, Gabriela Roman, Blaženko Vukovic, Nikolaos Papanas, Dario Rahelić, Nebojsa Lalic
Publikováno v:
Diabetes Therapy
Therapeutic inertia related to insulin treatment, i.e. delays in initiation, especially titration of basal insulin, is a significant problem in daily practice in Southeast European countries. This phenomenon can be traced back to several patient-, ph
Autor:
Gian Paolo Fadini, Cristobal Morales, Irene Caballero, Beatriz González, Nikolaos Tentolouris, Agostino Consoli
Gian Paolo Fadini,1 Cristobal Morales,2 Irene Caballero,2 Beatriz González,2 Nikolaos Tentolouris,3 Agostino Consoli4 1Division of Metabolic Diseases, Department of Medicine, University of Padova, Padua, Italy; 2Hospital Virgen Macarena (Sevilla);
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dbe7322ba4b6e21714ba14eac4ae822
https://hdl.handle.net/11577/3473090
https://hdl.handle.net/11577/3473090
Autor:
Panagiotis Theodorou, Nikolaos Tentolouris, Panagiotis Tsiligros, Petros Kostagiolas, Dimitrios Niakas
Publikováno v:
Library Hi Tech. 39:448-461
PurposeThe purpose of this paper is the investigation of type 2 diabetes patients' information seeking behavior in terms of their information needs, sources and barriers faced by patients when seeking information. The information seeking behavior is
Autor:
Yasushi Fukushima, Harpreet S. Bajaj, Tsvetalina Tankova, Nikolaos Tentolouris, Anette L. Søndergaard, John B. Buse, Juan P. Frias, Ildiko Lingvay, Pernille Auerbach, Stanislava Macura
Publikováno v:
Diabetes. 70
Once-weekly (OW) subcutaneous semaglutide 0.5 and 1.0 mg are approved maintenance doses for type 2 diabetes (T2D) treatment. We hypothesized that a higher dose of 2.0 mg would provide additional glycemic control with more patients achieving treatment
Autor:
Christina Darviri, Alexandros Kokkinos, Dimitrios S. Simos, Eleni Zigkiri, Maria Charalampopoulou, George P. Chrousos, Elena Aggelopoulou, Efstathios S. Gonos, Flora Bacopoulou, Nikolaos Tentolouris, Sophia Athanasopoulou
Publikováno v:
Mechanisms of ageing and development. 198
Stress accelerates aging by affecting relevant cellular pathways including, among others, leucocyte telomere length (LTL) and proteasome levels. Their impaired function underlies several age-related and non-communicable conditions, such as type 2 dia
Autor:
Yasushi Fukushima, Pernille Auerbach, Stanislava Macura, Ildiko Lingvay, Juan P. Frias, Anette L. Søndergaard, Nikolaos Tentolouris, Tsvetalina Tankova, John B. Buse, Harpreet S. Bajaj
Publikováno v:
The lancet. Diabetesendocrinology. 9(9)
Summary Background Semaglutide is an effective treatment for type 2 diabetes; however, 20–30% of patients given semaglutide 1·0 mg do not reach glycaemic treatment goals. We aimed to investigate the efficacy and safety of once-weekly semaglutide 2
Autor:
Ioannis Mitroulis, Petros P. Sfikakis, Athanase D. Protogerou, Aigli-Ioanna Legaki, Michael Koutsilieris, Nikolaos Tentolouris, Akrivi Chrysanthopoulou, Konstantinos Ritis, Antonios Chatzigeorgiou
Publikováno v:
Thrombosis and Haemostasis. 120:1587-1589